We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
93 hedge funds and large institutions have $158M invested in Puma Biotechnology in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,100% more call options, than puts
Call options by funds: $4.64M | Put options by funds: $211K
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
35% more capital invested
Capital invested by funds: $117M → $158M (+$40.8M)
30% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 27
13% more funds holding
Funds holding: 82 → 93 (+11)
4.97% more ownership
Funds ownership: 56.73% → 61.7% (+5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
93
Holders Change
+11
Holders Change %
+13.41%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
20
Increased
35
Reduced
27
Closed
9
Calls
$4.64M
Puts
$211K
Net Calls
+$4.43M
Net Calls Change
+$3.81M
Top Buyers
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$15.2M |
| 2 |
Goldman Sachs
New York
|
+$1.8M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$1.68M |
| 4 |
Jane Street
New York
|
+$1.57M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.42M |
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$6.22M |
| 2 |
ACM
Athyrium Capital Management
New York
|
-$2.88M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.67M |
| 4 |
EP
Eversept Partners
New York
|
-$1.45M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.02M |
